Analysts expect Rocket Pharmaceuticals, Inc. to report revenue of 205,788.00 for Q3 26, against a range of 188,945.90 to 222,630.10. The most recent reported quarter, Q2 26, came in at 0.00, a 100.0% miss against the 17.26 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 30,616.88 | 7.12 M | 0.00 | 316,874.94 | 0.00 | 0.00 | 17.86 M | 222,630.10 | 711,945.97 | 3.25 M | 4.15 M | 2.68 M | 2.71 M | 7.67 M | 8.88 M | ||||||||||
| Low Estimate | 0.00 | 27,982.72 | 5.92 M | 0.00 | 266,959.44 | 0.00 | 0.00 | 16.65 M | 188,945.90 | 627,850.93 | 2.79 M | 3.46 M | 2.29 M | 2.37 M | 6.79 M | 7.66 M | ||||||||||
| Consensus Estimate | 0.00 | 29,299.80 | 6.52 M | 0.00 | 291,917.19 | 0.00 | 0.00 | 17.26 M | 205,788.00 | 669,898.45 | 3.02 M | 3.81 M | 2.48 M | 2.54 M | 7.23 M | 8.27 M |
Analysts expect Rocket Pharmaceuticals, Inc. to report earnings per share of -0.38 for Q3 26, against a range of -0.39 to -0.37. The most recent reported quarter, Q2 26, came in at 1.08, a 20.0% beat against the 0.90 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.71 | -0.62 | -0.56 | -0.62 | -0.45 | -0.38 | -0.42 | 1.08 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.71 | -0.70 | -0.52 | -0.56 | -0.50 | -0.44 | -0.38 | 0.94 | -0.37 | -0.39 | -0.33 | -0.34 | -0.70 | -0.56 | -0.21 | 0.04 | ||||||||||
| Low Estimate | -0.85 | -0.84 | -0.64 | -0.60 | -0.54 | -0.50 | -0.46 | 0.86 | -0.39 | -0.47 | -0.39 | -0.40 | -0.82 | -0.64 | -0.23 | 0.04 | ||||||||||
| Consensus Estimate | -0.78 | -0.77 | -0.58 | -0.58 | -0.52 | -0.47 | -0.42 | 0.90 | -0.38 | -0.43 | -0.36 | -0.37 | -0.76 | -0.60 | -0.22 | 0.04 |
Pull Wall Street consensus for Rocket Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RCKT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RCKT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RCKT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();